Delaware Heparin Deaths May Be Isolated
The Food and Drug Administration has announced that the deaths of two patients treated with possibly contaminated heparin may have been an isolated incident.
Five patients recently fell ill in a Delaware medical center after being treated with heparin IV bags supplied by Baxter International. Two of the patients, a 71-year-old man and a 64-year-old woman, have died, and a third patient remains hospitalized. These three people all suffered cerebral hemorrhages.
However, the FDA has found no evidence of contamination, nor have they received additional reports of fatalities or other serious injuries linked to heparin use. The FDA has determined that this incident alone is not enough to make any decisions about the production of heparin. FDA representatives have issued statements that patients should not worry about being treated with heparin.
Anyone who has suffered a defective drug injury should contact an experienced lawyer immediately as they may be eligible to receive compensation through a defective drug lawsuit.